Scaling required 100,000 employees. Today, staff use 750 custom GPTs to automate workflows from dose verification to contract review.
A biotechnology pioneer famous for its mRNA COVID-19 vaccine aims to launch 15 new products in the next five years while maintaining a lean workforce.
Scaling to this output level using traditional biopharmaceutical methods would require 100,000 employees, far exceeding the company's sustainable...
“We believe very profoundly at Moderna that ChatGPT and what OpenAI is doing is going to change the world. We’re looking at every business process—from legal, to research, to manufacturing, to commercial—and thinking about how to redesign them with AI.”
Biotechnology company developing messenger RNA (mRNA) therapeutics and vaccines.
AI research and deployment company developing generative models and tools.
Related implementations across industries and use cases
Translating technical docs took weeks. Now, AI agents mimic human teams to draft, edit, and verify clinical reports in minutes.
Staff manually gathered specs across scattered systems. Now, 1,400 custom GPTs fetch data via APIs and automate quality compliance.
Teams reactively managed trials across scattered systems. AI now integrates data to predict bottlenecks and recommend interventions.
Silos forced teams to manually chase data. Now, AI agents identify adverse events in seconds, eliminating weeks of cross-referencing.
Attorneys juggled fragmented tools to search 50,000 cases. An AI orchestrator now routes queries to sub-agents in a single chat.
Experts spent 15 minutes pulling data from scattered systems. Natural language prompts now generate detailed reports instantly.
Lab supply orders were handwritten in notebooks. Digital ordering now takes seconds, saving 30,000 hours for research annually.